22nd century tobacco Reports $4.1M in Revenue as it Focuses on Future FDA Should Reject Claims on
FDA Should Reject Claims on Very Low Nicotine Cigarettes (VLNC) FDA Authorizes Marketing of 22nd Century Group's VLN as a Modified Risk Tobacco Product Be Korea savvy VLN Products 22nd Century Group Inc 22nd Century Files Modified Risk Tobacco Product Application With FDA 22nd Century expands markets and brand agreements for VLN products TobaccoIntelligence
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



